Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Crinetics Pharmaceuticals

Tracked across 4 events · 86 articles · First seen Jul 06, 2026 · Last active Aug 06, 2026

Sentiment
48
Attention
6
Events
4
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 80
Business
Impact: Crinetics is being acquired by Vertex for $85 per share, providing shareholders with a premium. Its key assets include approved drug Palsonify and late-stage candidate atumelnant.
Jul 06, 2026 · 34 articles
4 70
Business
Impact: Crinetics is being acquired by Vertex for $10 billion, adding endocrine disorder treatments to Vertex's portfolio. The deal is expected to close in Q3 and is likely to provide a significant premium to Crinetics shareholders.
Aug 03, 2026 · 7 articles
1 -10
Regulatory
Monteverde & Associates PC, a securities class action firm, has launched and continued investigations into numerous proposed mergers and acquisitions on behalf of shareholders. The firm is examining the terms of transactions involving companies such…
Impact: Target of investigation regarding its sale to Vertex Pharmaceuticals; shareholders may receive $85 per share, but the inquiry could affect the deal.
Jul 20, 2026 · 20 articles
4 50
Business
Impact: Crinetics Pharmaceuticals was acquired by Vertex, contributing to the favorable M&A environment.
Jul 06, 2026 · 25 articles
Vertex Pharmaceuticals acquisition target Crinetics Pharmaceuticals Crinetics Pharmaceuticals is the target of an acquisition by Vertex Pharmaceutic
Vertex Pharmaceuticals acquirer Crinetics Pharmaceuticals Vertex Pharmaceuticals is acquiring Crinetics Pharmaceuticals for $10 billion to
ERGEN INTELLIGENCE
Track Crinetics Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.